Sepsis Research Blood Sample Collection Services
Responses closed . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM EDT
- Posted
- September 1, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY
- Place of performance
- Maryland, 21044
- PSC
- AN11: HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- HT942523P0084
- Notice ID
- e06e19115b9a4f3199c1197138e469d8
Description
Notice of Intent (NOI) to Sole Source
Title: Sepsis Research Blood Sample Collection Services
Requiring Activity: Walter Reed Army Institute of Research (WRAIR), Integrative Systems Biology (ISB) Branch
Related Notice: HT942523P0084
Product Service Code (PSC): AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
North American Industry Classification System (NAICS) Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Small Business Size Standard: 1000 employees
The Defense Health Agency Contracting Activity (DHACA) on behalf of the Integrative Systems Biology (ISB) Branch at the Walter Reed Army Institute of Research (WRAIR) intends to extend current contract services as a cost R&D contract on a sole source basis to Medstar Health Research Institute, Inc. (MHRI), 10980 Grantchester Way 7th Fl, Columbia, MD 21044-6097 USA; Cage Code 3J1M2 under the RFO FAR 6.103-1 – Only one responsible source can supply the required products due to the non-commercially available sources of the blood samples the Government is requesting.
Description of Requirement: This is a requirement to extend and re-structure a Firm-Fixed Price contract into a Research and Development (R&D) cost type contract vehicle that will allow the Integrative Systems Biology (ISB) Branch to procure samples from septic and non-septic burn patients along with longitudinal clinical data for the assessment of biomarkers of sepsis for refinement and validation of SeptiBurnAlert program. These blood samples; to include longitudinal clinical data, are currently being collected by MHRI in accordance with an approved Institutional Review Board (IRB) protocol and are actively recruiting subjects for patient samples that meet the specific thermally injured criteria. The Government will convert the current contract from a firm fixed price award to a cost type, RFO part 35 R&D contract to better align the requirement with the Government’s needs.
This special notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether competitive procurement is in the best interest of the Government.
If no meaningful, written submissions are received by the date listed below, after the publication of this notice, the solicitation will be issued as a sole source requirement to Medstar Health Research Institute, Inc. Based on the above information, the only technically acceptable vendor to fulfill this requirement is MHRI.
Submit capability statements (using PDF, MS Word, or Excel attachments) to Ms. Nicole Applegate at e-mail: nicole.v.applegate.civ@health.mil
Capability statements are due no later than 10:00am Eastern Time on October 15, 2026.
Award Overview
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
- 1Version 1Special NoticeCurrent
Sepsis Research Blood Sample Collection Services
Similar Opportunities
Additional Details
Solicitation Number
HT942523P0084
Archive Date
Oct 30, 2026
Office Address
FORT DETRICK, MD, 21702